glp-1 prefilled syringes for glp-1 Glp1 and Syringe Case GLP-1 Pricing Preview - Combat

Shibata N, Nagai R, Uchida K, Horiuchi S, Yamada S, Hirano A, et al

Bringing their heavyweight battle in GLP-1 brand marketing into the federal courts, category founder Novo Nordisk on Tuesday sued category leader Eli Lilly to stop what it calls multiple misleading national ad campaigns. In one such campaign, which began early this year, Lilly cites a study showing that users of its Zepbound weight loss med lost an average 50 pounds versus just 33 pounds for users of Novo Nordisks Wegovy

References Royal College of Pathologists of Australasia

Morusin, a novel inhibitor of ACLY, induces mitochondrial apoptosis in hepatocellular carcinoma cells through ROS-mediated mitophagy